期刊文献+

替米沙坦与贝那普利联合应用对老年高血压患者左心室肥厚的影响 被引量:1

Effect of Telmisartan and Benazepril on left ventricular hypertrophy in elderly hypertensive patients
下载PDF
导出
摘要 目的:探讨替米沙坦与贝那普利联合应用对老年高血压患者左心室肥厚的影响。方法:回顾性分析2014年3月到2016年3月收治的100例老年高血压左心室肥厚患者的临床资料。分为实验组(替米沙坦与贝那普利联合应用治疗)和对照组(替米沙坦治疗),每组各50例。对比两组患者动态血压(ABPM)、舒张末期室间隔厚度(IVST)、舒张末期左心室后壁厚度(PWI)、舒张末期左心室内经(LVDd)、左心室质量指数(LVMI)。结果:治疗后,两组患者左心室肥厚情况均获得改善,其中实验组ABPM、IVST、PWI、LVDd、LVMI均优于对照组(P<0.05)。结论:替米沙坦与贝那普利联合治疗老年高血压患者效果显著,可以更好的改善患者的左心室肥厚、高血压情况。 Objective:To investigate the effect of Telmisartan and Benazepril on left ventricular hypertrophy in elderly hypertensive patients.Methods:The clinical data of 100 elderly patients with hypertension and left ventricular hypertrophy admitted between March 2014 and March 2016 were retrospectively analyzed.All patients were divided into the study group(Telmisartan and Benazepril) and control group(Telmisartan),n=50 in each group.The ambulatory blood pressure monitoring(ABPM),end-diastolic interventricular septum thickness(IVST),end-diastolic left ventricular posterior wall thickness(PWI),left ventricular end-diastolic diameter(LVDd),and left ventricular mass index(LVMI) were compared between the two groups.Results:After the treatment,the left ventricular hypertrophy was improved in both groups.The ABPM,IVST,PWI,LVDd and LVMI in the study group were better than those in the control group(P<0.05).Conclusion:Using Telmisartan and Benazepril in the treatment of elderly hypertensive patients is effective,which may better improve left ventricular hypertrophy and hypertension.
作者 陈锦雄 张勇辉 古作飞 邹利添 甘秀梅 Chen Jinxiong;Zhang Yonghui;Gu Zuofei;Zou Litian;Gan Xiumei(Department of Internal Medicine,Anliu Health Center,Meizhou,Guangdong 514435,China)
出处 《广州医科大学学报》 2018年第4期48-50,共3页 Academic Journal of Guangzhou Medical University
关键词 左心室肥厚 替米沙坦 贝那普利 老年高血压 动态血压 Left ventricular hypertrophy Telmisartan Benazepril elderly hypertension ambulatory blood pressure
  • 相关文献

参考文献6

二级参考文献44

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3055
  • 2陆志明,余叶蓉.胰岛素抵抗与凝血、纤溶功能异常的关系[J].医学研究生学报,2003,16(11):864-865. 被引量:10
  • 3卢伟,刘美霞,李锐,傅华,金泰廙,张胜年.上海15~74岁居民代谢综合征的流行特征[J].中华预防医学杂志,2006,40(4):262-268. 被引量:135
  • 4朱吉基,李舟跃.替米沙坦与贝那普利联合应用对老年高血压患者左心室肥厚的影响[J].中国基层医药,2007,14(3):398-399. 被引量:5
  • 5Malhotra A, Kang BP, Cheung S, et al. Angiotensin II promotes glucose- induced activation of cardiac protein kinase C isozymes and phosphory-lation oftroponin I [J].Diabetes,2001,50:191g-1926.
  • 6Abuissa H, Jones PG, Marso SP, et al. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials [J]. J Am Coil Cardiol,2005,46(5):821-826.
  • 7Bumier M, Branner HR. Angiotensin II receptor antagonist [J]. Lancet,2000, 355:637-645.
  • 8Clasen R, Schupp M, Foryst-Luduig A, et al. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin [J]. Hypertension, 2005,46( 1): 137-143.
  • 9Benson SC, Pershadsingh HA, Ho I, et al. Identification of Telmisartan as a unique angiotensin II receptor antagonist with selective PPARmodulating activity [J], Hypertension,2004,43(5):993-1002.
  • 10Duncan BB, Schmidt MI. Chronic activation of the innate immune system may underlie the metabolic syndrome [J]. Sao Paulo Med J,2001,119(3): 122-127.

共引文献16

同被引文献18

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部